Naproxen sodium tablets, 220 mg
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Naproxen sodium tablets, 220 mg, covering 2019-11-06 to 2019-11-06. Get the full timeline:
Most recent: FDA Approved: NAPROXEN SODIUM — Supplemental Application (CVS)